2-178610341-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BP4_Strong
The NM_001267550.2(TTN):c.51185G>A(p.Ser17062Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.51185G>A | p.Ser17062Asn | missense_variant | 271/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.51185G>A | p.Ser17062Asn | missense_variant | 271/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152028Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460656Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726626
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152028Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 05, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ser14494Asn v ariant in TTN has not been previously reported in individuals with cardiomyopath y or in large population studies. Computational prediction tools do not provide strong support for or against an impact to the protein. Serine (Ser) at position 14494 is not well conserved in evolution with 2 mammals (pika and star-nosed mo le), multiple birds, as well as several reptiles and fish species having an aspa ragine (Asn) at this position, suggesting that this change may be tolerated. In summary, while the clinical significance of the p.Ser14494Asn variant is uncerta in, the presence of the variant amino acid in multiple other species suggests th at it is more likely to be benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 14, 2021 | Variant summary: TTN c.43481G>A (p.Ser14494Asn) results in a conservative amino acid change located in the A-band of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 248358 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.43481G>A has been reported in the literature in one individual affected with HCM (Lopes_2013). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. Co-occurrence with a pathogenic variant has been reported (MYBPC3 c.484C>T, p.Gln162X), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 14, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at